Certara 发布 Secondary Intelligence™ 软件,可提前预测候选药物的不良副作用风险
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress PRINCETON, NJ – 2021 年 5 月 4 日, Certara, Inc. (纳斯达克股票代码:CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from … Continued